<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68652">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01675440</url>
  </required_header>
  <id_info>
    <org_study_id>10050361DOC</org_study_id>
    <nct_id>NCT01675440</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Very High Risk Subjects Who Need Aortic Valve Replacement</brief_title>
  <official_title>Medtronic CoreValve® U.S. Expanded Use Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to evaluate the safety and effectiveness of the
      Medtronic CoreValve® System (MCS) in a subset of subjects excluded from the U.S. Extreme
      Risk Pivotal Trial population due to one or more additional co-morbidities, as measured by a
      composite of all-cause death or major stroke at 12 months, in the treatment of symptomatic
      severe aortic stenosis in subjects necessitating aortic valve replacement.  Subjects
      enrolled in this study have a predicted operative mortality or serious, irreversible
      morbidity risk of ≥50% at 30 days associated with surgical aortic valve replacement.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">550</enrollment>
  <condition>Severe Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Severe (≥3-4+) mitral valve regurgitation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe (≥3-4+) tricuspid valve regurgitation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>End stage renal disease (ESRD)</arm_group_label>
    <description>requiring renal replacement therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low gradient, low output aortic stenosis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>2 or more conditions</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Failed bioprosthetic surgical aortic valve</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</intervention_name>
    <arm_group_label>Severe (≥3-4+) mitral valve regurgitation</arm_group_label>
    <arm_group_label>Severe (≥3-4+) tricuspid valve regurgitation</arm_group_label>
    <arm_group_label>End stage renal disease (ESRD)</arm_group_label>
    <arm_group_label>Low gradient, low output aortic stenosis</arm_group_label>
    <arm_group_label>2 or more conditions</arm_group_label>
    <arm_group_label>Failed bioprosthetic surgical aortic valve</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with symptomatic severe aortic stenosis requiring aortic valve replacement, with
        predicted operative mortality or serious, irreversible morbidity risk of ≥ 50% at 30 days,
        and at least one of the following conditions:

          -  Severe (≥3-4+) mitral valve regurgitation

          -  Severe (≥3-4+) tricuspid valve regurgitation

          -  End stage renal disease (ESRD) requiring renal replacement therapy

          -  Low gradient, low output aortic stenosis

          -  Failed bioprosthetic surgical aortic valve

          -  2 or more conditions (listed above)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject must have co-morbidities such that one cardiologist and two cardiac surgeons
             agree that medical factors preclude operation, based on a conclusion that the
             probability of death or serious morbidity exceeds the probability of meaningful
             improvement.  Specifically, the predicted operative risk of death or serious,
             irreversible morbidity is ≥ 50% at 30 days.

          -  Subjects must meet all of the criteria under at least one of the sub-groups 2a-c:

             a. Senile degenerative aortic valve stenosis and i. At least one of the following
             co-morbid conditions:

               1. Severe (≥3-4+) mitral valve regurgitation as     measured by echocardiography

               2. Severe (≥3-4+)  tricuspid valve regurgitation as measured by echocardiography

               3. End-stage renal disease requiring renal replacement therapy (Stage 5 of the
                  KDOQI CKD Classification)

                  AND

                  ii. mean gradient &gt; 40 mmHg or jet velocity greater than 4.0 m/sec by either
                  resting or dobutamine stress echocardiogram (if the LVEF &lt; 50%), or simultaneous
                  pressure recordings at cardiac catheterization either resting or with dobutamine
                  stress (if the LVEF &lt; 50%), AND iii. an initial aortic valve area of ≤ 0.8 cm2
                  (or aortic valve area index ≤0.5 cm2/m2) by resting echocardiogram or
                  simultaneous pressure recordings at cardiac catheterization

                  AND/OR

                  b. Low gradient, low output aortic stenosis as defined by the presence of all
                  three of the following i. In the presence of LVEF &lt;50%, absence of contractile
                  reserve, a mean gradient &lt;40mmHg AND jet velocity less than 4.0m/sec with
                  dobutamine stress echocardiography or simultaneous pressure recordings at
                  cardiac catheterization OR In the presence of LVEF ≥50%, a mean gradient &lt;40mmHg
                  AND jet velocity  less than 4.0 m/sec, by echocardiography or simultaneous
                  pressure recordings at cardiac catheterization ii. an initial aortic valve area
                  of ≤0.8 cm2 (or aortic valve area index ≤0.5 cm2/m2) by resting echocardiogram
                  or simultaneous pressure recordings at cardiac catheterization AND iii.
                  radiographic evidence of severe aortic valve calcification c. Failed
                  bioprosthetic surgical aortic valve

          -  Subject is symptomatic from his/her aortic valve stenosis, as demonstrated by New
             York Heart Association (NYHA) Functional Class II or greater.

          -  The subject or the subject's legal representative has been informed of the nature of
             the study, agrees to its provisions and has provided written informed consent as
             approved by the IRB of the respective clinical site.

          -  The subject and the treating physician agree that the subject will return for all
             required post-procedure follow-up visits.

        Exclusion Criteria:

        Clinical

          -  Evidence of an acute myocardial infarction ≤30 days before the MCS TAVI procedure.

          -  Any percutaneous coronary or peripheral interventional procedure performed within 30
             days prior to the MCS TAVI procedure

          -  Blood dyscrasias as defined: leukopenia (WBC &lt;1000mm3), thrombocytopenia (platelet
             count &lt;50,000 cells/mm3), history of bleeding diathesis or coagulopathy.

          -  Untreated clinically significant coronary artery disease requiring revascularization.

          -  Cardiogenic shock manifested by low cardiac output, vasopressor dependence, or
             mechanical hemodynamic support.

          -  Need for emergency surgery for any reason.

          -  Severe ventricular dysfunction with left ventricular ejection fraction (LVEF) &lt;20% as
             measured by resting echocardiogram.

          -  Recent (within 6 months) cerebrovascular accident (CVA) or transient ischemic attack
             (TIA).

          -  Active Gastrointestinal (GI) bleeding within the past 3 months.

          -  Hypersensitivity or contraindication to aspirin, heparin, ticlopidine, clopidogrel,
             warfarin, nitinol, or sensitivity to contrast media which cannot be adequately
             pre-medicated.

          -  Ongoing sepsis, including active endocarditis.

          -  Subject refuses a blood transfusion.

          -  Life expectancy &lt;12 months due to associated non-cardiac co-morbid conditions.

          -  Other medical, social, or psychological conditions that in the opinion of an
             Investigator precludes the subject from appropriate consent.

          -  Severe dementia (resulting in either inability to provide informed consent for the
             study/procedure, prevents independent lifestyle outside of a chronic care facility,
             or will fundamentally complicate rehabilitation from the procedure or compliance with
             follow-up visits).

          -  Currently participating in an investigational drug or another device study.

          -  Symptomatic carotid or vertebral artery disease.

        Anatomical

          -  Native aortic annulus size &lt;18 mm or &gt;29 mm per the baseline diagnostic imaging.

          -  Pre-existing prosthetic heart valve in the any position

          -  Moderate to severe mitral stenosis.

          -  Mixed aortic valve disease: aortic stenosis and aortic regurgitation with predominant
             aortic regurgitation, (AR is moderate-severe to severe (≥3-4+))(except for failed
             surgical bioprothesis)

          -  Hypertrophic obstructive cardiomyopathy.

          -  Echocardiographic evidence of new or untreated intracardiac mass, thrombus or
             vegetation.

          -  Severe basal septal hypertrophy with an outflow gradient.

          -  Aortic root angulation (angle between plane of aortic valve annulus and horizontal
             plane/vertebrae) &gt;70° (for femoral and left subclavian/axillary access) and &gt;30° (for
             right subclavian/axillary access).

          -  Ascending aorta that exceeds the maximum diameter for any given native aortic annulus
             size (see table below) Aortic Annulus Diameter Ascending Aorta Diameter 18 mm - 20 mm
             &gt;34 mm 20 mm - 23 mm &gt;40 mm 23 mm - 27 mm &gt;43 mm 27 mm - 29 mm &gt;43 mm

          -  Congenital bicuspid or unicuspid valve verified by echocardiography.

          -  Sinus of valsalva anatomy that would prevent adequate coronary perfusion.

          -  Degenerated surgical bioprothesis presents with a significant concomitant
             perivalvular leak (between prothesis and native annulus), is not securely fixed in
             the native annulus, or is not structurally intact (e.g. wireform frame fracture)
             (ONLY FOR TAV in SAV subjects)

          -  Degenerated surgical bioprothesis presents with a partially detached leaflet that in
             the aortic position may obstruct a coronary ostium (ONLY FOR TAV in SAV subjects)

        Vascular

          -  Transarterial access not able to accommodate an 18Fr sheath.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Erin McDowell</last_name>
    <email>RS.CSTechSupport@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Banner Good Samaritan</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Byrne, MD</last_name>
    </contact>
    <investigator>
      <last_name>Timothy Byrne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Caskey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicken Aharonian, MD</last_name>
    </contact>
    <investigator>
      <last_name>Vicken Aharonian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Pfeffer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ray Matthews, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ray Matthews, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vaughn Starnes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>El Camino Hospital</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>James Joye, MD</last_name>
    </contact>
    <investigator>
      <last_name>James Joye, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincent Gaudiani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Giacomini, MD</last_name>
    </contact>
    <investigator>
      <last_name>John Giacomini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Robbins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond McKay, MD</last_name>
    </contact>
    <investigator>
      <last_name>Raymond McKay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Hagberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Thompson, MD</last_name>
    </contact>
    <investigator>
      <last_name>Craig Thompson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Elefteriades, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center / Georgetown Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ron Waksman, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ron Waksman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ammar Bafi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Health System / Jackson Memorial Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo de Marchena, MD</last_name>
    </contact>
    <investigator>
      <last_name>Eduardo de Marchena, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomas Salerno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nirat Beohar, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nirat Beohar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Lamelas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vivek Rajagopal, MD</last_name>
    </contact>
    <investigator>
      <last_name>Vivek Rajagopal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Kauten, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis Heller, MD</last_name>
    </contact>
    <investigator>
      <last_name>Louis Heller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Macheers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferdinand Leya, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ferdinand Leya, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mamdouh Bakhos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Heart Center of Indiana</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Hermiller, MD</last_name>
    </contact>
    <investigator>
      <last_name>James Hermiller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Heimansohn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Atul Chawla, Md</last_name>
    </contact>
    <investigator>
      <last_name>Atul Chawla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Hockmuth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Tadros, MD</last_name>
    </contact>
    <investigator>
      <last_name>Peter Tadros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>George Zorn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South/Terrebonne General</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Fail, MD</last_name>
    </contact>
    <investigator>
      <last_name>Peter Fail, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edgar Feinberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jon Resar, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jon Resar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Conte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey J Popma, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jeffrey J Popma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kamal Khabbaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health Systems</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanley J Chetcuti, MD</last_name>
    </contact>
    <investigator>
      <last_name>Stanley J Chetcuti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>G. Michael Deeb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Davis, MD</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Davis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sanjay Batra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Detroit Medical Center Cardiovascular Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theodore Schreiber, MD</last_name>
    </contact>
    <investigator>
      <last_name>Theodore Schreiber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ali Kafi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospitals</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Merhi, DO</last_name>
    </contact>
    <investigator>
      <last_name>William Merhi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Heiser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morristown Memorial Hospital</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Kipperman, MD</last_name>
    </contact>
    <investigator>
      <last_name>Robert Kipperman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Brown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanley Katz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Stanley Katz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alan Hartman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Cohen, MD</last_name>
    </contact>
    <investigator>
      <last_name>Howard Cohen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valavanur Subramanian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Slater, MD</last_name>
    </contact>
    <investigator>
      <last_name>James Slater, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aubrey Galloway, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David H Adams, MD</last_name>
    </contact>
    <investigator>
      <last_name>David H Adams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samin Sharma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Petrossian, MD</last_name>
    </contact>
    <investigator>
      <last_name>George Petrossian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Newell Robinson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Kevin Harrison, MD</last_name>
    </contact>
    <investigator>
      <last_name>J. Kevin Harrison, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>G. Chad Hughes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest University - Baptist Medical Center</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Applegate, MD</last_name>
    </contact>
    <investigator>
      <last_name>Robert Applegate, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Neal Kon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals - Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Costa, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alan Markowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco Costa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Yakubov, MD</last_name>
    </contact>
    <investigator>
      <last_name>Steven Yakubov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Watson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Medical Center - The Richard M. Ross Heart Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Cheatham, MD</last_name>
    </contact>
    <investigator>
      <last_name>John Cheatham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan Crestanello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Skelding, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kimberly Skelding, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alfred Casale, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brijeshwar Maini, MD</last_name>
    </contact>
    <investigator>
      <last_name>Brijeshwar Maini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mubashir Mumtaz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William D Anderson, MD</last_name>
    </contact>
    <investigator>
      <last_name>William D Anderson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas G Gleason, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Zhao, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Zhao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Bryne, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Heart and Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Stoler, MD</last_name>
    </contact>
    <investigator>
      <last_name>Robert Stoler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Hebeler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute at St. Luke's Episcopal Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Diez, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jose Diez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Coselli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital - The Methodist DeBakey Heart &amp; Vascular Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neal Kleiman, MD</last_name>
    </contact>
    <investigator>
      <last_name>Neal S Kleiman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Reardon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fletcher Allen Healthcare</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harold Dauerman, MD</last_name>
    </contact>
    <investigator>
      <last_name>Harold Dauerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Schmoker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bryan Raybuck, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bryan Raybuck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Niv Ad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Sacred Heart Medical Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mike Ring, MD</last_name>
    </contact>
    <investigator>
      <last_name>Mike Ring, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leland Siwek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center - Aurora Health Care</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanvir Bajwa, MD</last_name>
    </contact>
    <investigator>
      <last_name>Tanvir Bajwa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel O'Hair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 18, 2013</lastchanged_date>
  <firstreceived_date>August 22, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
